- MVD and primary PCI: which strategy?
- 'The Great Debate' - Dual antiplatelet therapy - Which drug? For which patient? For which stent? For how long?
- 'The Great Debate' - Diffuse Coronary artery disease - Available options? New strategies on the Horizon? How to best optimise the options?
- Is what you see really what you get?
- FFR assessment of coronary stenoses in series
- View more...
- Home
- |
- PCR FOCUS GROUP ON BIORESORBABLE VASCULAR SCAFFOLDS – MARCH 2012
PCR FOCUS GROUP ON BIORESORBABLE VASCULAR SCAFFOLDS – MARCH 2012
EBAC attendance certificate
Receive your EBAC attendance certificate: click here
Download the programme
Get the full programme in a PDF format. Includes: focus group objectives, faculty, session details, general information.
[8] Thursday 08 Mar
| Main Room | |
|---|---|
|
Session 1: A glance to the past and the ABC of polymer bioresorption
Chairperson: Waksman Ron |
08:10 - 09:30 |
| LIVE CASE 1: Live from MC Erasmus - Thorax centre (Implantation or FUP of ABSORB) | 09:30 - 10:15 |
|
Session 2: Understanding the basics of polymer bioresorption in vitro - Part I
Chairperson: Vert Michel |
10:45 - 12:00 |
| LIVE CASE 2: Live from MC Erasmus - Thorax centre (Diabetic case) | 12:00 - 12:45 |
|
Session 3: Understanding the basics of polymer bioresorption in vivo - Part II
Chairperson: Van Beusekom Heleen |
13:45 - 15:00 |
| LIVE CASE 3: Live from Erasmus MC (Long-term FUP of Cohort A with positive non-invasive FFR in non-target vessel [5 or 13]) | 15:00 - 15:45 |
|
Session 4: New insights into imaging modalities to assess different aspects of BVS
Chairperson: Bruining Nico |
16:10 - 18:15 |
|
Closing remarks Day 1
Chairperson: van Geuns Robert-Jan |
18:15 - 18:25 |
[7] Friday 09 Mar
| Main Room | |
|---|---|
| Welcome Day 2 | 08:00 - 08:10 |
|
Session 5: Clinical physiopathology insight
Chairperson: Regar Evelyn |
08:10 - 09:20 |
| LIVE CASE 4: Live from Maasstad (ABSORB Extend, demo of overlap on OCT) | 09:20 - 10:05 |
|
Session 6: CLINICAL DATA: Current status - Part I
Chairperson: Smits Peter |
10:30 - 12:35 |
|
Session 6: CLINICAL DATA: Current status - Part II
Chairperson: Smits Peter |
13:30 - 14:10 |
| LIVE CASE 5: Live from Maasstad (ABSORB Physiology) | 14:10 - 15:00 |
|
Session 7: Seminal observations on new patient/ lesion type
Chairperson: van Geuns Robert-Jan |
15:00 - 16:30 |
EDITORIAL FOCUS
Now EBAC accredited for 20 External CME credits
Continuing medical education (CME), sometimes referred to as continuing professional development (CPD), is an integral part of a medical practitioners’ commitment to life-long learning following postgraduate specialty training. There are many activities that count towards the goal of achieving sufficient knowledge and skills to remain up-to-date.
VIDEO OF THE DAY
AsiaPCR/SingLIVE 2013 How should I treat?Recently commented lectures
-
1 -
Champion Phoenix: anti-ischaemic effects of cangrelor during PCI
[…]
-
2 -
Conservative strategy for right coronary artery perforation
[…]
-
3 -
How should I treat? Distal Left Main Stenosis involveming the origin of LAD and LCX with severe proximal tortuacity and Triple Vessels Diseases in a Patient with Unstable Angina and Renal Artery Stenosis
[…]
-
4 -
Intracoronary adrenaline for resistant Noreflow during PCI in acute coronary syndrome
[…]
-
5 -
Acute stent thrombosis
[…]
-
6 -
An unusual approach to treatment of a challenging bifurcation lesion
[…]
-
7 -
Stent fracture managed by covered stent
[…]
-
8 -
Challenging aberrant right coronary artery origin PCI
[…]
-
9 -
Massive dissection of right coronary artery during CAG and small RV branch perforation by guide wire during bail out stentig
[…]
-
10 -
How to safely perform TAVI in case of pre-implanted metallic prosthetic mitral valve?
[…]

